
Kamal A. Saeed
Examiner (ID: 13000, Phone: (571)272-0705 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 3146 |
| Issued Applications | 2344 |
| Pending Applications | 317 |
| Abandoned Applications | 526 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17110044
[patent_doc_number] => 20210290641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => EP4 INHIBITORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/187900
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187900 | EP4 INHIBITORS AND USE THEREOF | Feb 28, 2021 | Abandoned |
Array
(
[id] => 18732582
[patent_doc_number] => 11801302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Formulations and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/186548
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 57066
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186548 | Formulations and uses thereof | Feb 25, 2021 | Issued |
Array
(
[id] => 18271628
[patent_doc_number] => 20230092870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => MARGARIC ACID DECREASES PIEZ02-MEDIATED PAIN
[patent_app_type] => utility
[patent_app_number] => 17/799500
[patent_app_country] => US
[patent_app_date] => 2021-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799500 | MARGARIC ACID DECREASES PIEZ02-MEDIATED PAIN | Feb 20, 2021 | Pending |
Array
(
[id] => 16946588
[patent_doc_number] => 20210205279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => SOLID DISPERSION FORMS OF RIFAXIMIN
[patent_app_type] => utility
[patent_app_number] => 17/174829
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174829 | Solid dispersion forms of rifaximin | Feb 11, 2021 | Issued |
Array
(
[id] => 18337796
[patent_doc_number] => 20230129745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/760093
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760093 | COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE | Feb 7, 2021 | Pending |
Array
(
[id] => 17065775
[patent_doc_number] => 20210267990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHOD FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/167200
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17167200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/167200 | METHOD FOR TREATING CANCER | Feb 3, 2021 | Abandoned |
Array
(
[id] => 17314964
[patent_doc_number] => 20210404012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-PROLIFERATIVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/164336
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164336 | Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease | Jan 31, 2021 | Issued |
Array
(
[id] => 17014075
[patent_doc_number] => 11083694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Injectable phenol formulations and methods of their use
[patent_app_type] => utility
[patent_app_number] => 17/160951
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9858
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160951 | Injectable phenol formulations and methods of their use | Jan 27, 2021 | Issued |
Array
(
[id] => 17014076
[patent_doc_number] => 11083695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Injectable phenol formulations and methods of manufacture
[patent_app_type] => utility
[patent_app_number] => 17/160993
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9896
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160993 | Injectable phenol formulations and methods of manufacture | Jan 27, 2021 | Issued |
Array
(
[id] => 16837778
[patent_doc_number] => 20210145790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHOD FOR PROVIDING EARLY ONSET OF ACTION IN THE TREATMENT OF ROSACEA
[patent_app_type] => utility
[patent_app_number] => 17/156941
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156941 | Method for providing early onset of action in the treatment of rosacea | Jan 24, 2021 | Issued |
Array
(
[id] => 18836747
[patent_doc_number] => 11844804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Administration of testosterone compositions
[patent_app_type] => utility
[patent_app_number] => 17/157310
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 22900
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157310 | Administration of testosterone compositions | Jan 24, 2021 | Issued |
Array
(
[id] => 19026313
[patent_doc_number] => 11925653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Combination therapy effective against microorganisms, including drug resistant microorganisms
[patent_app_type] => utility
[patent_app_number] => 17/157993
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17408
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157993 | Combination therapy effective against microorganisms, including drug resistant microorganisms | Jan 24, 2021 | Issued |
Array
(
[id] => 18886344
[patent_doc_number] => 11865100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Method for treatment of rosacea in patients aged 65 years and older
[patent_app_type] => utility
[patent_app_number] => 17/154689
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9945
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154689 | Method for treatment of rosacea in patients aged 65 years and older | Jan 20, 2021 | Issued |
Array
(
[id] => 18916691
[patent_doc_number] => 11878961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer
[patent_app_type] => utility
[patent_app_number] => 17/153340
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 47
[patent_no_of_words] => 8972
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153340 | Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer | Jan 19, 2021 | Issued |
Array
(
[id] => 18762870
[patent_doc_number] => 11813249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Combination therapy for treatment of restenosis
[patent_app_type] => utility
[patent_app_number] => 17/149631
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 51
[patent_no_of_words] => 27530
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149631
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/149631 | Combination therapy for treatment of restenosis | Jan 13, 2021 | Issued |
Array
(
[id] => 18799986
[patent_doc_number] => 11833129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Thiophene compound for treatment of exfoliating glaucoma
[patent_app_type] => utility
[patent_app_number] => 17/149549
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 20
[patent_no_of_words] => 15407
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/149549 | Thiophene compound for treatment of exfoliating glaucoma | Jan 13, 2021 | Issued |
Array
(
[id] => 16969272
[patent_doc_number] => 11065218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Compositions and methods for treating chronic inflammation and inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 17/146950
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 37225
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146950 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Jan 11, 2021 | Issued |
Array
(
[id] => 17074840
[patent_doc_number] => 11111224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Benzothia(di)azepine compounds and their use as bile acid modulators
[patent_app_type] => utility
[patent_app_number] => 17/144568
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 33125
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144568 | Benzothia(di)azepine compounds and their use as bile acid modulators | Jan 7, 2021 | Issued |
Array
(
[id] => 16946559
[patent_doc_number] => 20210205250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT
[patent_app_type] => utility
[patent_app_number] => 17/140733
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140733 | CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT | Jan 3, 2021 | Abandoned |
Array
(
[id] => 19490595
[patent_doc_number] => 12109280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Oil-in-water emulsion comprising an amphiphilic polymer
[patent_app_type] => utility
[patent_app_number] => 17/140720
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17795
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140720 | Oil-in-water emulsion comprising an amphiphilic polymer | Jan 3, 2021 | Issued |